RDS Batch-Bot

Numina Group’s RDS™ Warehouse Execution and Control Software Suite now includes a new Batch Bot Module to optimize, manage and track (AMR) activities, explains Numina Group CEO Dan Hanrahan.

Woodridge, IL (PRWEB)
March 09, 2020

Numina Group and Waypoint Robotics have teamed up to create a powerful autonomous batch order automated order picking solution. Numina Group’s Real-time Distribution Software, RDS™ Batch Bot Voice Picking Application integrates with Waypoint Robotics’ Vector Autonomous Mobile Robot, (AMR) to provide an innovative, highly efficient order picking solution. The RDS™ automation module uses pick by voice commands to direct operator zone movement and picking tasks while coordinating the Waypoint Vector AMR batch cart movement throughout the distribution center (DC). The AMRs, using the Kingpin technology, efficiently pick-up and move carts with heavy and/or large quantities of orders, allowing the operators to focus on the high value order picking duties. The Vector AMR Kingpin connects and drops carts quickly, resulting in higher hourly throughput per cart, and a more efficient pick, pack, and ship operation.

The solution simultaneously coordinates both the Waypoint AMR and order picking to eliminate wasted operator walk time and fatigue caused by manually pushing carts with up to 600 pounds of products throughout the DC. RDS™ directs the Vector AMR with Kingpin pick and drop technology, so the pick carts automatically move to each shelf or rack location. At pick completion RDS™ directs the AMR to transport the finished carts to packing workstations. Vector combined with the RDS™ Batch Bot solution provides higher order fulfillment efficiency, reducing labor costs by 40% or more compared to a manual cart picking process.

“Numina Group’s RDS™ Warehouse Execution and Control Software Suite now includes a new Batch Bot Module to optimize, manage and track (AMR) activities,” explains Numina Group CEO Dan Hanrahan. “The new software module extends the capabilities of our RDS™ Pick by Voice picking application so both the workers and the autonomous batch cart movements are coordinated throughout pick and pack. The Batch Bot module includes order release and prioritization, cartonization pick to carton, put to light order consolidation, and labor and order tracking performance metrics reporting.”

“Waypoint’s Kingpin is the first of its kind dual-use module that enables Vector and MAV3K AMRs to automatically load and unload payloads as well as hitch and transport carts of all sizes,” says Waypoint Robotics CEO, Jason Walker. “Now you don’t have to dedicate a robot for one task or another, with Kingpin you can do both. This combined with Numina Groups RDS order fulfillment automation suite creates a powerful but easy to use solution to improve worker productivity and safety by reducing the heavy lifting.”

About Numina Group:

Numina Group is a top tier integrator for improving and automating warehouse operations through a family of cutting-edge warehouse automation technologies managed and controlled by RDS™, our top tier WCS-WES Platform. The Numina Group partners with clients to define, design, and implement material handling and order fulfillment process improvements enhanced by automation technologies that optimize distribution practices to gain improved profitability.

Numina Group

10331 Werch Drive

Woodridge, IL 60517

630-343-2622

info@numinagroup.com

https://numinagroup.com/

@pickpackship

About Waypoint Robotics:

Waypoint Robotics, located in Nashua, NH, develops and manufactures fully autonomous mobile robots that are easy to use, industrial strength, and designed to be setup and used by the workforce that is on the job today. VectorTM, MAV3KTM, and supporting products can be put to work immediately, adding to workers’ capabilities, increasing their efficiency, and strengthening their companies.

Waypoint Robotics, Inc.

248 Main Dunstable Road

Nashua, NH 03062

603-288-1605

info@waypointrobotics.com

http://www.waypointrobotics.com

@waypointrobo

Share article on social media or email:

Kajeet, Inc.

We have seen our company evolve from serving primarily education clients… to the Fortune 100, and other enterprises that value our technology, expertise and services, in particular, our Sentinel® cloud platform.

MCLEAN, Va. (PRWEB)
March 04, 2020

Kajeet, Inc., commonly known as Kajeet and stylized as kajeet, announced today the consolidation of its brands Kajeet and Otarris into Kajeet, Inc. This consolidation is part of Kajeet’s one brand strategy, which leverages the major successes of each brand to provide customers with a seamless wireless connectivity experience.

Kajeet is the foremost provider of wireless solutions to school districts across America, deploying wireless solutions to bridge the digital divide and keep children safe. Otarris provides enterprise customers with wireless connectivity solutions and wireless data intelligence capabilities to inform their business decisions. Together, the two brands support over 5 million connected devices across multiple verticals and have always been focused on delivering reliable, innovative, and high-value customer-centric wireless solutions. Under one Kajeet, Inc. brand, the company will synergize its shared objectives, existing partnerships in a wide range of industries, and the knowledge and expertise of its wireless solutions engineers across the globe to enhance its growth and service delivery.

“The initial phase of our journey more than 15 years ago gave us tremendous experience and laid a strong foundation for our innovative technology platform, our deep collective expertise in wireless and cloud software, and our expanding pool of intellectual property,” said Daniel Neal, CEO, and Founder of Kajeet, Inc. “We have seen our company evolve from serving primarily education clients in the K-12 space to working on behalf of major cable companies, public safety service providers in the Fortune 100, and other enterprises that value our technology, expertise and services, in particular, our Sentinel® cloud platform. As a unified brand, Kajeet plans to build on our excellent and well-earned reputation in the market to help clients compete in this rapidly evolving, increasingly connected world.”

Kajeet plans to accelerate its innovation of vertical solutions and continue to offer customers the flexibility of its Sentinel platform to manage policies and data on mobile devices. “Sentinel will be the centerpiece of our combined strategy. We plan to incorporate the best features of all of our product lines into our modular platform to deliver outstanding solutions to our customers,” said Neal.

The corporate rebrand will have no impact on the company’s structure, client relationships, or service delivery. Legacy websites will continue to be functional until the launch of a consolidated website in the coming months.

About Kajeet

Kajeet®, Inc., is the industry leader for highly-managed multi-network mobile solutions, and for deploying private wireless networks across multiple industry verticals. Our secure, cloud-based SaaS platform, Sentinel®, allows our clients to centrally manage network security and filtering; policy, device and network controls; data consumption rates; business analytics; and allows for operation on all 6 major north American wireless networks. Kajeet products and services are protected by the following issued U.S. patents: 10,313,532; 10,285,025; 10,057,300; 10,009,480; 9,237,433; 9,137,389; 9,137,386; 9,125,057; 8,995,952; 8,929,857; 8,918,080; 8,774,755; 8,774,754; 8,755,768; 8,731,517; 8,725,109; 8,712,371; 8,706,079; 8,667,559; 8,644,796; 8,639,216; 8,634,803; 8,634,802; 8,634,801; 8,630,612; 8,611,885; 8,600,348; 8,594,619; 8,588,735; 8,285,249; 8,078,140; 7,945,238; 7,899,438; 7,881,697. Other patents are pending. For more information, please visit us at 45,238; 7,899,438; 7,881,697. Other patents are pending. For more information, please visit KajeetBusiness.com.

###

Kajeet, Inc.

If you would like more information, please call Marcia Degnan, Director of Marketing at 240-482-3500, or email mdegnan@kajeet.com.

Nina von Mouillard joins M3 Global research as business development director.

“We are delighted to welcome Nina to M3 and know that she will bring energy and drive to the role,” says Anton Richter, CEO, M3 Global Research.

FORT WASHINGTON, Pa. (PRWEB)
March 04, 2020

Von Mouillard Brings Nine Years of Healthcare Market Research Experience to M3

M3 Global Research, the leading healthcare market research company, has announced that Nina von Mouillard has joined the firm’s EU division as business development director, with a remit focusing on the growth and expansion of M3’s qualitative market research services.

This appointment reinforces M3’s 2020 commitment to invest heavily in its qualitative research solutions, and von Mouillard is seen as vital in broadening M3’s market presence, given her stellar reputation and extensive industry experience. Her commitment to high quality deliverables and client satisfaction matches M3’s aspirations to ensure excellent customer relations at every touchpoint.    

“We are delighted to welcome Nina to M3 and know that she will bring energy and drive to the role,” says Anton Richter, CEO, M3 Global Research. “Her passion for her clients, combined with our growth ambitions and investment in qualitative research innovations make for a very exciting Q2 and beyond.”

“We’re confident that Nina’s focus on our qualitative solutions will consolidate our market position,” says Tom Pugh, M3 Global Research EVP, “but she will also serve as a great mentor and educator for her junior business development colleagues, strengthening the department as a whole.”

Von Mouillard joins M3 Global Research from The Research House, where she served as Director of Client Solutions. She has previously held positions at Schlesinger Group Companies Schmiedl Marktforschung GmbH, in Berlin and Consumed Research in Paris. She is fluent in German, English, French, and Spanish.

“I am thrilled to join M3, a leading MR company that has a reputation for excellent client service and innovation,” adds von Mouillard. “I wanted a new challenge in my career and given my professional focus on strategic business development, I’m excited to work with our clients to deliver best-in-class qualitative solutions.”

Nina’s first day with M3 Global Research was the 2nd of March. She reports directly to Nina Engelbrekt, SVP, Client Services at M3 Global Research.

ABOUT M3 GROUP

The M3 Group operates in the US, Asia, and Europe with over 4 million physician members globally via its physician websites which include mdlinx.com, m3.com, research.m3.com, Doctors.net.uk, medigate.net, and medlive.cn. M3 Inc. is a publicly traded company on the Tokyo Stock Exchange (jp:2413) with subsidiaries in major markets including the US, UK, Japan, South Korea, and China. The M3 Group provides services to healthcare and the life science industry. In addition to market research, these services include medical education, ethical drug promotion, clinical development, job recruitment, and clinic appointment services. M3 has offices in Japan, UK, France, Germany, Brazil, Sweden, China, India, and South Korea, as well as the US.

CONTACT

Press contact Sue Krause, Sr. Marketing Director at +1 267 805 3359 or email at marketing@usa.m3.com or visit http://www.M3GlobalResearch.com

Share article on social media or email:

WASHINGTON (PRWEB)
March 04, 2020

Today, Enforme (http://www.enforme.com) announced the launch of the Enforme Association Incubator, a complete software and services package, right-sized for the needs of a new association. From web-presence to membership management to e-commerce, to management consulting, the Enforme Association Incubator delivers a fully integrated solution. It is, in the words of one partner organization, “an association in-a-box.”

For over twenty years, Enforme has had the privilege of serving some of the world’s most prominent and innovative professional associations. Together, we’ve worked to reimagine the ways in which associations create member value. We’ve done this through data-driven design, collaboration, and co-innovation.

Acknowledging that seed funding is often the biggest obstacle to launching a new association, Enforme offers the Association Incubator program with no upfront costs. Enforme is rolling out this service with a novel revenue sharing business model designed to align economic incentives and foster a mutually beneficial long-term relationship.

These collaborations have given us a unique perspective on the most urgent strategic challenges facing professional associations. Our experience enables a unique understanding of associations, especially those that are making the difficult transition from concept to launch.

“There has never been a time of such rapid and profound change in business, science and medicine. New business and scholarly communities are being launched to nurture these exciting emerging disciplines,” said Carrie Delente, Co-Founder and COO of Enforme. “The Enforme Association Incubator program is specifically designed to meet their unique needs.”

The Enforme Association Incubator program is a flexible and complete software package, designed with the new association in mind. From web-presence to membership management to e-commerce, it is a fully integrated solution. This highly integrated program can enable a fledgling association to move from concept to go-live in as little as 6-10 weeks.

In addition to technical support at every step in the journey, Enforme also offers marketing, branding, business management and sales support. “While a robust online presence is an essential component of a new association, technology alone is insufficient,” said Kevin Fitzpatrick, President and CEO of Enforme. “Enforme provides the organizational and business support to ensure operational excellence.”

More on the Enforme Association Incubator program can be found at enforme.com.

About Enforme:

Enforme, a well-established custom solutions provider for medical associations, was founded by Carrie Delente in 1997. Enforme’s award-winning team has provided non-profit associations with highly customized cutting-edge design, development, and technical best practices. From websites and apps to online learning, member management, and content delivery, Enforme provides essential services for professional associations across the globe.

Share article on social media or email:

YORBA LINDA, Calif. (PRWEB)
March 05, 2020

LabRoots, the leading scientific social networking website offering premier, interactive virtual events and webinars, will be hosting approximately 15,000 neuroscience researchers, clinicians, and scientists from around the globe who are dedicated to understanding the brain and nervous system. The annual, free Neuroscience Virtual Event will capture emerging developments in Neuroscience and the impact brain research has on society, together with the latest innovations.

With nearly 70 speakers, including two stellar keynote deliveries, 15 on-demand discussions, and 13 panels, Neuroscience 2020 showcases an extremely comprehensive program supported by the organizing committee of renowned academia and industry experts, The NIH BRAIN team, and dedicated sponsors.

Featuring neural circuit and behavior dynamics, cell diversity, tool and technology development, advancing human neuroscience: basic to clinical projects, and neuroethics presented by early career scientists diverse in background, The NIH BRAIN Initiative session will preview “a multidisciplinary approach to neuroscience.” The agenda also highlights the scourge of neurodegenerative diseases and dementia, and behavioral and psychiatric disorders to expand on the all-encompassing theme of the conference – brain function in health and disease.

This year’s agenda commences with a keynote academia speaker, Dario Alessi, FRS FMedSci FRSE, Director, Professor of Signal Transduction at University of Dundee, describing the nuts and bolts of the LRRK2 signaling pathway and how it is linked to Parkinson’s Disease, and new approaches that could be exploited to better diagnose the disease. Following, Dr. Walter Koroshetz, Director of the National Institute of Neurological Disorders and Stroke who played a significant role in the revolution in acute stroke care in the US and the growth of the neurointensive care field, will deliver a keynote presentation on The BRAIN Initiative and its promise for new Neurotechnologies to more effectively diagnose and treat neuro/mental/substance abuse disorders.

The featured notable speakers cover many significant areas of Neuroscience including open science and data sharing for behavioral neuroscience, understanding the pitfalls and advantages of cognitive testing in mouse models of disease, deciphering the spreading of neuropathologies in neuronal circuits using a high capacity microfluidics platform, and learning about a protein that is a potential key player in neurodegeneration and aging, and much more.

“This year’s Brain Initiative track will showcase the power of combining diverse expertise and teamwork in tackling some of the most challenging areas of contemporary neuroscience research,” commented Karen K. David, Ph.D., Program Director, BRAIN Initiative. “We are excited to feature through LabRoots the breadth of expertise of our early-career scientists and representative collaborative projects that tackle the circuit basis of behavior, cell diversity, resource development, and human neuroscience. Through Labroots’ virtual environment, we are able to feature the team neuroscience approach that can often be difficult to showcase through usual channels including conferences.”

“Progressing at a remarkable pace, Neuroscience is one of the most exciting fields of biomedical research and our interactive forum continues to lead our mission in sharing cutting-edge science on a global front,” said Greg Cruikshank, Chief Executive Officer of LabRoots. “We look forward to deepening the knowledge through valuable discussions, as the research of the human brain continues to evolve.”

Produced on LabRoots’ robust platform, this online environment with exhibit and poster halls, and networking lounge allows attendees to connect seamlessly across all desktop and mobile devices. By participating in this event, Continuing Education credit (1 per presentation) can be earned for a maximum of 40 credits.

For more information or to register for the event, click here. Participants can follow the conversation online by using #LRneuro.

About LabRoots

LabRoots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.

Share article on social media or email:

Cytonus is thrilled to gain the benefit of Phoenestra’s scientific excellence, quality IP assets, as well as the top talent of their highly experienced executives, who have decades of biopharma industry experience and were instrumental in the past development of more than eleven biologics that are n

SAN DIEGO (PRWEB)
March 05, 2020

With numerous products in its pipeline, Cytonus Therapeutics Inc. today announced a strategic partnership agreement with Phoenestra GmbH to accelerate Cytonus’ existing products and to expand the companies’ intellectual property assets. Cytonus is a biotech company founded in San Diego, California. Phoenestra is a biotech company located in Austria.

Phoenestra has developed IP assets in connection with cell reprogramming as well as non-invasive sources for cell lines. The strategic partnership with Cytonus will expand both companies’ combined IP assets through co-development collaboration projects. As part of the strategic partnership, Phoenestra will also provide Cytonus new manufacturing capabilities, including a new production facility focused on operating in full compliance with Good Manufacturing Practices (GMP). Since its inception, Phoenestra has focused on an end-to-end approach to ensure both quality control and scalability, starting with the efficient sourcing of material from unique cell sources and producing finished GMP-certified products.

“We are honored to join forces with Cytonus,” commented Phoenestra CEO and Founder Klaus Graumann, PhD. “Phoenestra will work to complement and accelerate Cytonus’ game-changing Cargocyte™ biotechnologies.”

“Our co-development projects will create fertile ground for further expanding the combined IP assets and pipeline of products for Cytonus and Phoenestra,” commented Phoenestra CFO and Founder Otto Kanzler.

“Cytonus is thrilled to gain the benefit of Phoenestra’s scientific excellence, quality IP assets, as well as the top talent of their highly experienced executives, who have decades of biopharma industry experience and were instrumental in the past development of more than eleven biologics that are now commercial products,” commented Cytonus’ Founder and CEO Remo Moomiaie-Qajar, MD.

About Cytonus Therapeutics Inc.

Cytonus Therapeutics Inc. is a San Diego based biotech company that has developed a vast platform of proprietary immunotherapeutic products to treat a wide range of medical conditions including cancers, infectious diseases, inflammatory diseases and cognitive disorders, and to improve patient outcomes. Its proprietary Cargocyte™ technologies are next-generation biomolecular delivery devices which have numerous medical applications across unmet therapeutic areas. Cargocytes™ are engineered to safely transport a multiplicity of therapeutic payloads into difficult-to-reach targeted tissues, and can be programmed to deliver selective, potent, and controllable “off-the-shelf” therapies. Cytonus’ vast platform of therapeutics and vaccines has the potential to improve the health and lives of people with life-threatening conditions. For more information, we invite you to visit the Cytonus website at https://Cytonus.com. Please follow us on Cytonus on LinkedIn and on Twitter at: @CytonusTx.

Statements in this news release other than strictly historical facts, such as statements about Cytonus’ plans and strategies, new and existing products and technologies, anticipated clinical and regulatory pathways, and markets for its products, are forward-looking statements. The words “believe,” “expect,” “aim,” “anticipate,” “estimate,” “project,” and similar expressions identify forward-looking statements that speak only as of the date hereof. Such statements involve risks and uncertainties that could cause actual results to differ materially from anticipated results due to many factors, including regulatory and development risks. The company undertakes no obligation to publicly update or revise any forward-looking statement. This news release is neither an offer to sell, nor the solicitation of any offer to purchase, any security.

Join Cytonus on LinkedIn and follow its Twitter account at: @CytonusTx

Share article on social media or email:

“[T]he renewed focus of the Complia Health leadership has made a significant difference in our business, and was instrumental in our decision to extend our ten-year contract for an additional five years.” —David Haslup, President and CEO, Interim HealthCare of Central Virginia

SCHAUMBURG, Ill. (PRWEB)
March 05, 2020

Complia Health announces a five-year ContinuLink contract extension with the Interim HealthCare franchise network, one of the largest home healthcare providers in the country. This contract extension bridges the current ten-year agreement between Interim HealthCare and Complia Health, ensuring a continuation of streamlined compliance, documentation and accounting for home healthcare billing processes.

Interim HealthCare is at the heart of the ContinuLink product. In 2008, the 350 Interim franchise owners realized there was an industry-wide need for a consistent medical billing product to manage multiple lines of business throughout various locations. As a result, the ContinuLink product was built from the ground-up with direct input from Interim franchise leaders.

The product launched successfully at the end of 2008 and eventually became a separate entity. Complia Health acquired ContinuLink in 2011, where it has remained a product of choice within the industry, helping clients navigate the complexities of home healthcare management while maximizing efficiencies and revenues.

“We consistently deliver on the always-changing regulatory requirements in the industry,” says Brad Caldwell, Chief Revenue Officer of Complia Health. “One of our greatest strengths is facilitating complex payers with multiple business lines, which gives our clients an advantage over their competitors.”

Two Interim HealthCare franchise owners are also part of Complia Health’s Customer Advisory Board see tremendous value in continuing the partnership with ContinuLink.

“We are not jeopardizing the backbone of our company by taking a risk on an unknown vendor in an unknown space,” says Devin Ringling, CEO of Interim HealthCare of Colorado Springs and a member of the Customer Advisory Board. “It only makes sense to continue our long-standing relationship with one of the best partners in the industry.”

Complia Health is committed to customer-centric care, ensuring that their industry-leading customers have the most current, regulatory-compliant products available. In addition to ContinuLink, the industry-changing Mobile Edge caregiver engagement tool satisfies both the Cures Act and EVV mandates. Mobile Edge works seamlessly with ContinuLink, making sure patient details are HIPPA-compliant and remotely accessible for home health caregivers utilizing the platform.

“The newly released Mobile Edge is also a game-changer for our caregivers, helping us meet compliance standards in a more streamlined manner,” says David Haslup, President and CEO of Interim HealthCare of Central Virginia. “Additionally, the renewed focus of the ContinuLink/Complia Health leadership has made a significant difference in our business, and was instrumental in our decision to extend our ten-year contract for an additional five years.”

Reach out to a solutions expert by calling 1.866.802.7704 or visit the ContinuLink information page to see firsthand why industry leaders like Interim HealthCare re-commit to ContinuLink for superior home healthcare software.

About Complia Health

Complia Health is a leading provider of technology and expertise for the post-acute and long-term care markets. Thousands of home health, hospice, palliative care, residential care, and community care locations count on Complia Health for the clinical, operational, and financial solutions required to profitability deliver quality care to their clients. Complia Health’s innovative products are supported by an industry-leading team of health and technology experts located in the United States. For more information, visit http://www.compliahealth.com.

Share article on social media or email: